Advancing innovation in accelerated cancer diagnosis
Innovate UKUK-wideVaries
Who can apply
This competition is open to collaborations only. To lead a collaborative project your organisation must be: a UK registered business an academic institution an NHS organisation The consortium must contain at least one UK registered micro, small or medium sized enterprise claiming grant funding on this application.
What it funds
Innovate UK, on behalf of the Office for Life Sciences' Cancer Healthcare Goals programme, will invest up to £25.4 million to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
Last checked against the official source: 28 Aug 2026. Scheme parameters are set by the funder and can change — verify before applying, or let us do it for you.
Ask about eligibility
Plain-English answers about this scheme's published criteria — not application advice.
Related schemes
Patent Box
HM Revenue & Customs
Reduces corporation tax to an effective 10% on profits attributable to patented inventions and certain other IP rights.
R&D Tax Relief (Merged Scheme & ERIS)
HM Revenue & Customs
Corporation tax relief on qualifying R&D expenditure. Merged scheme gives a 20% above-the-line credit (~15-16% net); loss-making R&D-intensive SMEs can claim enhanced support (ERIS) worth up to ~27p per £1 of qualifying spend.
Invest NI Grant for R&D
Invest Northern Ireland
Supports Northern Ireland businesses at every R&D stage, from feasibility to development — typical intervention 40-50% for SMEs.